TRPV1 and acute lymphoblastic leukemia: To determine the expression of TRPV1 in hematological malignancies, an in silico analysis was carried out across two clinical RNA-seq datasets and revealed a significantly higher expression of TRPV1 in patients with different subtypes of ALL in the MILE study compared to healthy normal bone marrow (P < 0.0001) (Fig. 1A).